Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 1Hypogonadism 1Eunuchism 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Interventional × testosterone undecanoate × Clear all
NCT02966652 2019-11-26

Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

Neurocrine UK Limited

Phase 1 Completed
25 enrolled

Eunuchism, Hypogonadism, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡